Talk:Ibogaine

From Wikipedia, the free encyclopedia

	Ibogaine was a nominee for Natural sciences good article, but did not meet the good article criteria at the time. There are suggestions below for improving the article. Once these issues have been addressed, the article can be renominated. Editors may also seek a reassessment of the decision if they believe there was a mistake.
September 13, 2007 Good article nominee Not listed

This article is within the scope of the following WikiProjects:

WikiProject Pharmacology (Rated B-Class) Ibogaine is part of WikiProject Pharmacology, a project to improve all Pharmacology-related articles. If you would like to help improve this and other pharmacology articles, please join the project. All interested editors are welcome. B This article has been rated as B-Class on the quality scale. High This article has been rated as high-importance for this Project's importance scale. WikiProject Psychedelics, Dissociatives and Deliriants (Rated B-Class) This article is part of WikiProject Psychedelics, Dissociatives and Deliriants, an attempt to improve Wikipedia's coverage of hallucinogens. Feel free to participate by editing this article or by visiting the project page, where you can join the project and/or contribute to the discussion. B This article has been rated as B-Class on the quality scale. WikiProject Alternative medicine      (Rated B-Class) Complementary and Alternative Medicine Portal This article is within the scope of the WikiProject on Alternative Medicine. Please visit the project page for more details, or ask questions on talk. B This article has been rated as B-class on the quality scale.

Archives

/Archive 1

Contents 1 New archive 2 Rewrite in progress 3 Rewrote intro 4 More rewriting underway 5 Research section - cardiac disorders 6 Alternative Treatment

[edit] New archive

Previous discussion archived to Talk:Ibogaine/Archive 1 on 9/26/2007.

[edit] Rewrite in progress

In order to satisfy the comments made in the failed "good article" review for this article, I will begin to do some rewrites in the next few days. I will leave comments here as I proceed. The Crow 16:40, 26 September 2007 (UTC)

[edit] Rewrote intro

I have rewritten the intro to bring it in line with the failed "good article" review which suggested: "An ideal lead section should be between 2-3 paragraphs, and introduce the reader to the contents of the article. It should contain engaging prose, designed to spark their interest and encourage them to read more.". I intentionally avoided the approach of coming mainly from a pharmacological/chemical angle as I think the ibogaine is a complex picture involving a number of equally important elements including African spiritual tradition, recreational drug culture, harm reduction, drug law, chemistry, etc. I made an effort to include all these things in equal balance. The Crow 14:48, 19 October 2007 (UTC)

[edit] More rewriting underway

Re-ordered and renamed some major sections. The intention is to draw the reader into the article with well-written general interest content, and segue into the more challenging technical material. Also I have made some edits to improve the flow of the prose and neutralize some bias here and there. I have completely removed the trivia section (formerly known as "media references" since it was implicated by the reviewer as one reason that this is not a good article (yet). The Crow (talk) 01:31, 12 December 2007 (UTC)

[edit] Research section - cardiac disorders

75.85.182.222 on March 6, 2008 questions the basis of the of the following information in the ibogaine article:

The National Institute on Drug Abuse (NIDA) abandoned efforts to continue this project into clinical studies in 1995, citing other reports that suggested a risk of brain damage with extremely high doses and fatal heart arrhythmia in patients having a history of health problems. 75.85.182.222 asks what is the basis for this claim? Is there a reference to confirm this?

Possibly, the writer meant "heart" problems rather than "health" problems. Setting that aside a significant subset of ibogaine-related fatalities were found to have prior cardiac disorders. These data are found in autopsy reports of the deceased, not generally available to the public. These findings are the reason for cardiac screening in persons proposed for ibogaine therapy. The state of the art screening now includes EKG and echo stress test for evaluation of cardiac disorders. Mbolo (talk) —Preceding comment was added at 02:52, 7 March 2008 (UTC)

[edit] Alternative Treatment

The alternative treatment section with the sole statement, "Comprehensive resources for those looking for recovery from addiction. <spamlink removed>" should be removed as commercial advertising having nothing to do with ibogaine.Mbolo (talk) 23:17, 22 May 2008 (UTC)

Already gone :) Fvasconcellos (t·c) 23:27, 22 May 2008 (UTC)